Cargando…

Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study

BACKGROUND: The long‐term trend in cancer death in a rapidly developing country provides information for cancer prophylaxis. Here, we aimed to identify the trends in cancer mortality in China during the 2004‐2018 period. METHODS: Using raw data from the national mortality surveillance system of Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Dongming, Zhang, Lijuan, Liu, Wenbin, Ding, Yibo, Yin, Jianhua, Ren, Rongbing, Li, Qi, Chen, Yifan, Shen, Jiaying, Tan, Xiaojie, Zhang, Hongwei, Cao, Guangwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504142/
https://www.ncbi.nlm.nih.gov/pubmed/34251754
http://dx.doi.org/10.1002/cac2.12195
_version_ 1784581271707451392
author Jiang, Dongming
Zhang, Lijuan
Liu, Wenbin
Ding, Yibo
Yin, Jianhua
Ren, Rongbing
Li, Qi
Chen, Yifan
Shen, Jiaying
Tan, Xiaojie
Zhang, Hongwei
Cao, Guangwen
author_facet Jiang, Dongming
Zhang, Lijuan
Liu, Wenbin
Ding, Yibo
Yin, Jianhua
Ren, Rongbing
Li, Qi
Chen, Yifan
Shen, Jiaying
Tan, Xiaojie
Zhang, Hongwei
Cao, Guangwen
author_sort Jiang, Dongming
collection PubMed
description BACKGROUND: The long‐term trend in cancer death in a rapidly developing country provides information for cancer prophylaxis. Here, we aimed to identify the trends in cancer mortality in China during the 2004‐2018 period. METHODS: Using raw data from the national mortality surveillance system of China, we assessed the mortalities of all cancer and site‐specific cancers during the 2004‐2018 period. The participants were divided into three age groups: ≥65 years, 40‐64 years, and ≤39 years. Changing trends in cancer death by gender, residency, and tumor location were estimated using fitting joinpoint models to log‐transformed crude mortality rates (CMRs) and age‐standardized mortality rates (ASMRs). RESULTS: Cancer death accounted for 24% of all‐cause of death in China during 2014‐2018. The CMR of all cancer was 150.0 per 100,000 persons. Cancer was the leading cause of death in the population <65 years. The six major cancer types (lung/bronchus cancer, liver cancer, stomach cancer, esophagus cancer, colorectal cancer, and pancreas cancer) accounted for 75.85% of all cancer deaths. The CMR of all cancer increased while the ASMR decreased during 2014‐2018 (P < 0.001). Lung/bronchus cancer and liver cancer were the leading causes of cancer death in the population <65 years, accounting for 45.31% (CMR) and 44.35% (ASMR) of all cancer death, respectively. The ASMR of liver cancer was higher in the 40‐64 years population than in the ≥65 years population, in contrast to the other five major cancers. The ASMRs of liver cancer, stomach cancer, and esophagus cancer decreased although they were higher in rural residents than in urban residents; the ASMRs of lung/bronchus cancer, colorectal cancer, and pancreas cancer increased in rural residents although they were higher in urban residents than in rural residents during 2014‐2018. CONCLUSION: Although the ASMR of all cancer decreased in China during 2004‐2018, lung/bronchus cancer and liver cancer remained the leading causes of cancer‐related premature death. Lung/bronchus cancer, colorectal cancer, and pancreas cancer increased in rural residents.
format Online
Article
Text
id pubmed-8504142
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85041422021-10-18 Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study Jiang, Dongming Zhang, Lijuan Liu, Wenbin Ding, Yibo Yin, Jianhua Ren, Rongbing Li, Qi Chen, Yifan Shen, Jiaying Tan, Xiaojie Zhang, Hongwei Cao, Guangwen Cancer Commun (Lond) Original Articles BACKGROUND: The long‐term trend in cancer death in a rapidly developing country provides information for cancer prophylaxis. Here, we aimed to identify the trends in cancer mortality in China during the 2004‐2018 period. METHODS: Using raw data from the national mortality surveillance system of China, we assessed the mortalities of all cancer and site‐specific cancers during the 2004‐2018 period. The participants were divided into three age groups: ≥65 years, 40‐64 years, and ≤39 years. Changing trends in cancer death by gender, residency, and tumor location were estimated using fitting joinpoint models to log‐transformed crude mortality rates (CMRs) and age‐standardized mortality rates (ASMRs). RESULTS: Cancer death accounted for 24% of all‐cause of death in China during 2014‐2018. The CMR of all cancer was 150.0 per 100,000 persons. Cancer was the leading cause of death in the population <65 years. The six major cancer types (lung/bronchus cancer, liver cancer, stomach cancer, esophagus cancer, colorectal cancer, and pancreas cancer) accounted for 75.85% of all cancer deaths. The CMR of all cancer increased while the ASMR decreased during 2014‐2018 (P < 0.001). Lung/bronchus cancer and liver cancer were the leading causes of cancer death in the population <65 years, accounting for 45.31% (CMR) and 44.35% (ASMR) of all cancer death, respectively. The ASMR of liver cancer was higher in the 40‐64 years population than in the ≥65 years population, in contrast to the other five major cancers. The ASMRs of liver cancer, stomach cancer, and esophagus cancer decreased although they were higher in rural residents than in urban residents; the ASMRs of lung/bronchus cancer, colorectal cancer, and pancreas cancer increased in rural residents although they were higher in urban residents than in rural residents during 2014‐2018. CONCLUSION: Although the ASMR of all cancer decreased in China during 2004‐2018, lung/bronchus cancer and liver cancer remained the leading causes of cancer‐related premature death. Lung/bronchus cancer, colorectal cancer, and pancreas cancer increased in rural residents. John Wiley and Sons Inc. 2021-07-12 /pmc/articles/PMC8504142/ /pubmed/34251754 http://dx.doi.org/10.1002/cac2.12195 Text en © 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Jiang, Dongming
Zhang, Lijuan
Liu, Wenbin
Ding, Yibo
Yin, Jianhua
Ren, Rongbing
Li, Qi
Chen, Yifan
Shen, Jiaying
Tan, Xiaojie
Zhang, Hongwei
Cao, Guangwen
Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
title Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
title_full Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
title_fullStr Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
title_full_unstemmed Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
title_short Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
title_sort trends in cancer mortality in china from 2004 to 2018: a nationwide longitudinal study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504142/
https://www.ncbi.nlm.nih.gov/pubmed/34251754
http://dx.doi.org/10.1002/cac2.12195
work_keys_str_mv AT jiangdongming trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT zhanglijuan trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT liuwenbin trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT dingyibo trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT yinjianhua trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT renrongbing trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT liqi trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT chenyifan trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT shenjiaying trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT tanxiaojie trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT zhanghongwei trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy
AT caoguangwen trendsincancermortalityinchinafrom2004to2018anationwidelongitudinalstudy